UNDIFFERENTIATED SARCOMA
Clinical trials for UNDIFFERENTIATED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED SARCOMA trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists reprogram immune cells to hunt deadly sarcomas
Disease control Recruiting nowThis early-stage study is testing the safety of a two-part treatment for advanced sarcomas that have stopped responding to standard therapies. Doctors take a patient's own immune cells, genetically modify them to recognize and attack cancer cells, and then infuse them back. These…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug trial targets tough childhood cancers that have returned
Disease control Recruiting nowThis study is testing a drug called lurbinectedin to see if it is safe and can control tumors in children and adults (age 10+) whose Ewing sarcoma or related cancers have come back after initial treatment. The drug is designed to target specific genetic changes that drive these t…
Matched conditions: UNDIFFERENTIATED SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC